Ashar Bhavesh
SEC insider (Form 3/4/5 filer). CIK 0001849740. Chief Operating Officer at Tyra Biosciences, Inc. (TYRA) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on May 5, 2026. Located in STAMFORD, CT.
Companies Ashar Bhavesh has filed insider reports for
- Tyra Biosciences, Inc. (TYRA): Officer, Chief Operating Officer
- SpringWorks Therapeutics, Inc. (SWTX): Officer, Chief Commercial Officer
Ashar Bhavesh
CIK: 0001849740
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- May 5, 2026TYRA
Tyra Biosciences, Inc.
AwardDirect15K shares- - Dec 1, 2025TYRA
Tyra Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
300K shares- - Jul 1, 2025SWTX
SpringWorks Therapeutics, Inc.
DispositionDirect62.1K shares- - Feb 20, 2025SWTX
SpringWorks Therapeutics, Inc.
SaleDirect1K shares at avg. $61.19$62K - Jan 10, 2025SWTX
SpringWorks Therapeutics, Inc.
AwardDirect17.3K shares- - Jan 6, 2025SWTX
SpringWorks Therapeutics, Inc.
Tax PaymentDirect2.3K shares at avg. $38.86$89K - Jan 5, 2025SWTX
SpringWorks Therapeutics, Inc.
Tax PaymentDirect3.8K shares at avg. $38.19$146K - Jan 4, 2025SWTX
SpringWorks Therapeutics, Inc.
Tax PaymentDirect4.5K shares at avg. $38.19$171K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 5, 2026 |  TYRA Tyra Biosciences, Inc. | Award | 15,013 | - | $0 | Direct |
| Dec 1, 2025 | TYRA Tyra Biosciences, Inc. | Award Stock Option (Right to Buy) | 300,000 | - | - | Direct |
| Jul 1, 2025 |  SWTX SpringWorks Therapeutics, Inc. | Disposition | 62,053 | - | - | Direct |
| Feb 20, 2025 | SWTX SpringWorks Therapeutics, Inc. | Sale | 1,016 | $61.19 | $62,168 | Direct |
| Jan 10, 2025 | SWTX SpringWorks Therapeutics, Inc. | Award | 17,323 | - | $0 | Direct |
| Jan 6, 2025 | SWTX SpringWorks Therapeutics, Inc. | Tax Payment | 2,284 | $38.86 | $88,756 | Direct |
| Jan 5, 2025 | SWTX SpringWorks Therapeutics, Inc. | Tax Payment | 3,825 | $38.19 | $146,077 | Direct |
| Jan 4, 2025 | SWTX SpringWorks Therapeutics, Inc. | Tax Payment | 4,475 | $38.19 | $170,900 | Direct |
1-8 of 8 transactions